Nuclear accumulation of fructose 1,6-bisphosphatase is impaired in diabetic rat liver

J Cell Biochem. 2012 Mar;113(3):848-56. doi: 10.1002/jcb.23413.


Using a streptozotocin-induced type 1 diabetic rat model, we analyzed and separated the effects of hyperglycemia and hyperinsulinemia over the in vivo expression and subcellular localization of hepatic fructose 1,6-bisphosphatase (FBPase) in the multicellular context of the liver. Our data showed that FBPase subcellular localization was modulated by the nutritional state in normal but not in diabetic rats. By contrast, the liver zonation was not affected in any condition. In healthy starved rats, FBPase was localized in the cytoplasm of hepatocytes, whereas in healthy re-fed rats it was concentrated in the nucleus and the cell periphery. Interestingly, despite the hyperglycemia, FBPase was unable to accumulate in the nucleus in hepatocytes from streptozotocin-induced diabetic rats, suggesting that insulin is a critical in vivo modulator. This idea was confirmed by exogenous insulin supplementation to diabetic rats, where insulin was able to induce the rapid accumulation of FBPase within the hepatocyte nucleus. Besides, hepatic FBPase was found phosphorylated only in the cytoplasm, suggesting that the phosphorylation state is involved in the nuclear translocation. In conclusion, insulin and not hyperglycemia plays a crucial role in the nuclear accumulation of FBPase in vivo and may be an important regulatory mechanism that could account for the increased endogenous glucose production of liver of diabetic rodents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Nucleus / enzymology*
  • Diabetes Mellitus, Experimental / enzymology*
  • Fructose-Bisphosphatase / analysis
  • Fructose-Bisphosphatase / metabolism*
  • Insulin / pharmacology
  • Liver / drug effects
  • Liver / enzymology*
  • Male
  • Phosphorylation
  • Rats
  • Rats, Sprague-Dawley


  • Insulin
  • Fructose-Bisphosphatase